Effects of azathioprine on response of renal anaemia to subcutaneous recombinant human erythropoietin.

AIMS: To determine the effect of concomitant azathioprine treatment on the response of patients with renal failure to treatment with subcutaneous recombinant human erythropoietin (r-HuEPO). METHODS: Two groups of patients with renal failure not receiving haemodialysis were studied. One comprised seven patients receiving erythropoietin alone, the second consisted of nine patients who were also treated with azathioprine. The haematological changes were monitored, and the functional erythropoietic response was studied by two different ferrokinetic models. One analysed the initial, the other the extended plasma iron clearance. Studies were performed before r-HuEPO treatment on all 16 patients, and repeated on 11 of these when the target haemoglobin (10-11 g/dl) was achieved and stabilised. Total erythropoiesis was determined using both techniques. Analysis of the extended plasma iron clearance also permitted calculation of both effective and ineffective erythroid activity. RESULTS: The haematological response to r-HuEPO was the same for both patient groups. Measurement of total erythropoiesis by both ferrokinetic methods showed good correlation. For those receiving long term azathioprine, the percentage ineffective erythropoiesis was high compared with that of the other patients, and remained so for as long as they continued with azathioprine. For those uncomplicated by azathioprine treatment, r-HuEPO increased levels of both effective and ineffective erythropoiesis by the same degree. A substantial reduction in ineffective erythropoiesis was shown only by those patients who either discontinued or reduced their azathioprine once they started r-HuEPO treatment. CONCLUSIONS: Azathioprine increases ineffective erythropoiesis. In this study, the r-HuEPO dose was sufficient to overcome this effect and promoted effective erythropoiesis so that the anaemia lessened. Measurement of total erythropoiesis provided limited information on the functional changes involved, differentiation of effective from ineffective erythropoiesis being necessary to define the changes after azathioprine reduction or withdrawal.

[1]  K. Hyde,et al.  Comparative ferrokinetic study with initial and extended iron clearance models. , 1991, Journal of clinical pathology.

[2]  J. Royston,et al.  Subcutaneous administration of recombinant human erythropoietin to subjects on continuous ambulatory peritoneal dialysis: an erythrokinetic assessment , 1990, British journal of haematology.

[3]  I. Cavill,et al.  The treatment of renal anaemia in CAPD patients with recombinant human erythropoietin. , 1990, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  I. Cavill,et al.  Subcutaneous recombinant erythropoietin in the treatment of renal anaemia in CAPD patients. , 1990 .

[5]  J. Adamson,et al.  Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. , 1989, The New England journal of medicine.

[6]  C. Winearls,et al.  SUBCUTANEOUS ERYTHROPOIETIN AND PERITONEAL DIALYSIS , 1989, The Lancet.

[7]  J. Boelaert,et al.  Comparative Pharmacokinetics of Recombinant Erythropoietin Administered by the Intravenous, Subcutaneous, and Intraperitoneal Routes in Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients , 1989, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[8]  J. Royston,et al.  Characterization of the anaemia of chronic renal failure and the mode of its correction by a preparation of human erythropoietin (r-HuEPO). An investigation of the pharmacokinetics of intravenous erythropoietin and its effects on erythrokinetics. , 1989, The Quarterly journal of medicine.

[9]  S. Rudnick,et al.  SUBCUTANEOUS ERYTHROPOIETIN , 1988, The Lancet.

[10]  C. Winearls,et al.  EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSIS , 1986, The Lancet.

[11]  C. H. Lin,et al.  Cloning and expression of the human erythropoietin gene. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Cazzola,et al.  Transferrin saturation, plasma iron turnover, and transferrin uptake in normal humans. , 1985, Blood.

[13]  J. Adamson,et al.  Anemia of end-stage renal disease (ESRD). , 1985, Kidney international.

[14]  E. Fritsch,et al.  Isolation and characterization of genomic and cDNA clones of human erythropoietin , 1985, Nature.

[15]  R. McGonigle,et al.  Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency. , 1984, Kidney international.

[16]  Wallner Sf,et al.  Evidence that inhibition of erythropoiesis is important in the anemia of chronic renal failure. , 1981 .

[17]  S. Wallner,et al.  Evidence that inhibition of erythropoiesis is important in the anemia of chronic renal failure. , 1981, The Journal of laboratory and clinical medicine.

[18]  C. Eaves,et al.  Erythropoietin (Ep) dose-response curves for three classes of erythroid progenitors in normal human marrow and in patients with polycythemia vera , 1978 .

[19]  C. Eaves,et al.  Erythropoietin (Ep) dose-response curves for three classes of erythroid progenitors in normal human marrow and in patients with polycythemia vera. , 1978, Blood.

[20]  I Cavill,et al.  Ferrokinetics and Erythropoiesis in Man: The Measurement of Effective Erythropoiesis, Ineffective Erythropoiesis and Red Cell Lifespan using 59Fe , 1975, British journal of haematology.

[21]  I. Cavill The preparation of 59Fe-labelled transferrin for ferrokinetic studies , 1971, Journal of clinical pathology.

[22]  International Committee for Standardization in Haematology , 1967 .

[23]  International Committee for Standardization in Haematology , 1967 .

[24]  J. Adamson,et al.  Erythropoiesis in patients with renal failure undergoing chronic dialysis. , 1967, The New England journal of medicine.

[25]  J. Naets The Kidney and Erythropoiesis , 1958, Nature.

[26]  P. Mollison,et al.  Red cell life-span in nephritis and in hepatic cirrhosis. , 1953, Clinical science.